Pharmaceuticals
The half-billion-dollar idea
April 8, 2013
While at MIT, alumnus Todd Zion developed an insulin product that ultimately drew the attention of a pharmaceutical giant.
Using biology to improve chemical synthesis
March 26, 2013
MIT team finds a more economical way to create valuable building blocks for pharmaceuticals
Also labeled: Biology, Chemistry and chemical engineering, Faculty, Graduate, postdoctoral, Medicine, Research
Research update: A new model accurately predicts three-dimensional sand flow
March 25, 2013
Model may be useful in improving the flow of grain in silos, and drug capsules in pharmaceutical manufacturing.
Also labeled: Computer modeling, Granular flow, Manufacturing, Mathematics, Mechanical engineering, Physics, Grain silos, Fluid dynamics
Researchers reverse Fragile X Syndrome symptoms in adult mice
March 19, 2013
Picower Institute neuroscientists use single dose of experimental drug; could prove promising for treatment of autism symptoms.
Also labeled: Autism, Biology, Neurology, Neuroscience, Picower Institute for Learning and Memory, Research
How better financing could help create new cancer drugs
October 4, 2012
MIT finance researchers say a diversified ‘megafund’ of securities could help the industry deliver new products to consumers.
New drug candidate shows promise against cancer
July 11, 2012
Platinum compound may offer an alternative to cisplatin, a widely used chemotherapy agent.
Also labeled: Cancer, Chemistry and chemical engineering, Chemotherapy, Cisplatin, Medicine, Platinum, Research, Stephen Lippard
Continuous drug manufacturing offers speed, lower costs
March 12, 2012
New system developed by MIT researchers could help transform the pharmaceutical industry.
Successful human tests for first wirelessly controlled drug-delivery chip
February 16, 2012
Clinical trial of the programmable, implantable device shows promise in treating osteoporosis.
Moving past trial and error
February 15, 2012
Richard Braatz applies math to design new materials and processes for drug manufacturing.
Digging for answers
November 22, 2011
MIT, Pfizer hold groundbreaking for new biomedical research facility in Kendall Square.
Making a Nobel-winning chemistry reaction even better
November 3, 2011
New catalyst offers greater control over the synthesis of organic cyclic compounds, including potential cancer drugs.
Also labeled: Catalyst, Chemistry and chemical engineering, Faculty, Nobel Prizes, Research, Metathesis
Pfizer expands its research footprint in Cambridge
September 1, 2011
Announces lease of space in building being developed by MIT
Five companies join the Center for Biomedical Innovation's NEWDIGS program
June 2, 2011
Bristol‐Myers Squibb, Johnson & Johnson, Life Technologies, Pfizer and Quintiles will support initiatives in regulatory science and oncology innovation.
More than just a pretty flower
November 4, 2010
MIT chemists engineer the periwinkle plant to produce compounds that could become more effective cancer drugs.
Nerve-cell regeneration quest is fast tracked
October 12, 2010
Microchip technology rapidly identifies compounds for regrowing nerves, in live animals.
Getting bacteria to do a plant’s job
October 1, 2010
Researchers engineer microbes for low-cost production of precursor of anticancer drug Taxol and other pharmaceuticals.
Squeezing more production out of bacteria
September 21, 2010
MIT chemical engineers demonstrate a new way to dramatically boost bacteria’s manufacturing abilities.
From sponges, a potential cancer drug
August 30, 2010
MIT chemists have synthesized a family of natural compounds that have shown promise in killing tumor cells.
Why saliva forms beads on a string
August 11, 2010
Researchers’ solution to longstanding mystery could enable better inkjet printing and drug-dispensing systems.
MIT’s Koch Institute in strategic partnership with Ortho-McNeil-Janssen Pharmaceuticals
June 28, 2010
Organizations will collaborate in multiple areas of oncology research and technology development.
An easier way to synthesize new drug candidates
June 25, 2010
MIT chemists’ answer to long-standing problem could have a big impact on pharmaceutical business.
Biomanufacturing Research Program wins grant from Sloan Foundation
April 13, 2010
Will be used to examine globalization and regulatory compliance
Also labeled: Awards, honors and fellowships, Biotechnology
Subscribe
